Search

Author/Creator Lau, Sai Ping

1. Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model. Issue 2 (20th July 2020)

Authors:
Lau, Sai Ping; van Montfoort, Nadine; Kinderman, Priscilla; Lukkes, Melanie; Klaase, Larissa; van Nimwegen, Menno; van Gulijk, Mandy; Dumas, Jasper; Mustafa, Dana A M; Lievense, Sanne L A; Groeneveldt, Christianne; Stadhouders, Ralph; Li, Yunlei; Stubbs, Andrew; Marijt, Koen A; Vroman, Heleen; va...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial). Issue 6 (16th June 2022)

Authors:
Lau, Sai Ping; van 't Land, Freek R; van der Burg, Sjoerd H; Homs, Marjolein Y V; Lolkema, Martijn P; Aerts, Joachim G J V; van Eijck, Casper H J
Journal:
BMJ open
Issue:
Volume 12:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗